Delivery Order SPE2DR25D7066-SPE2DR26F7ZNT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $6,119.27 on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed price delivery order represents a non-competitive set-aside contract and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $10,186.15 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The sensors will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Freestyle Libre 3 Plus Sensors with a ceiling value of $1,402.34. The order, which is firm fixed price with no set-aside designation, is scheduled for completion by December 17, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,234 delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $11,778.21 on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order represents a non-competitive award under a larger indefinite delivery contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,060.71 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on December 15, 2025, with an ultimate completion date of December 16, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The sensors will be performed at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $6,633.32 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The sensors will be delivered to AmerisourceBergen's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $11,598.25 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for continuous glucose monitoring supplies to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $4,368.94 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 17, 2025, with completion expected by October 20, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The sensors will be supplied from the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $19,652.04 for Freestyle Libre 3 Plus Sensors, with completion targeted for September 25, 2025. This non-competitive delivery order was issued on September 24, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZNTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors valued at $6,547.68 on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company maintains extensive delivery order activity under its DLA IDC, fulfilling medical supply needs across multiple therapeutic domains including diabetes management products, neurological treatments, pain management pharmaceuticals, and specialized medical devices. This particular delivery order for continuous glucose monitoring sensors aligns with the company's established role in supplying diabetes management and specialty medical commodities to support federal healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 12/18/25 |